semaglutide pancreatitis law firm in louisiana Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ Ozempic Lawsuit [2026 Update]

Wegovy is FDA-approved for weight loss for those with a body mass index (BMI) 30 or 27 with one or more weight-related comorbidities, such as heart disease or untreated high blood pressure

Shel: a handy tool for your weight loss belt

People drawn to microdosing often want the metabolic benefits of these therapies at a level that feels more tolerable: fewer side effects gentler appetite reduction or a more gradual experience overall Understanding what makes these two medications similar, and what sets them apart, is key to understanding why the comparison matters

International Price Differences Ozempic costs significantly less in Canada (approximately $300 to $400 USD monthly), the UK (approximately $200 to $300 USD monthly through NHS or private prescription), and many European countries where government healthcare systems negotiate prices